Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Lymphotoxin inhibits Chlamydia pneumoniae growth in HEp-2 cells.

Matsushima H, Shirai M, Ouchi K, Yamashita K, Kakutani T, Furukawa S, Nakazawa T.

Infect Immun. 1999 Jun;67(6):3175-9.

3.

Aspirin inhibits Chlamydia pneumoniae-induced nuclear factor-kappa B activation, cytokine expression, and bacterial development in human endothelial cells.

Tiran A, Gruber HJ, Graier WF, Wagner AH, Van Leeuwen EB, Tiran B.

Arterioscler Thromb Vasc Biol. 2002 Jul 1;22(7):1075-80.

4.

Inhibition of Chlamydia pneumoniae growth in HEp-2 cells pretreated with gamma interferon and tumor necrosis factor alpha.

Summersgill JT, Sahney NN, Gaydos CA, Quinn TC, Ramirez JA.

Infect Immun. 1995 Jul;63(7):2801-3.

5.

Foam cell formation inhibits growth of Chlamydia pneumoniae but does not attenuate Chlamydia pneumoniae-induced secretion of proinflammatory cytokines.

Blessing E, Kuo CC, Lin TM, Campbell LA, Bea F, Chesebro B, Rosenfeld ME.

Circulation. 2002 Apr 23;105(16):1976-82.

6.

Improvement of the mitochondrial antioxidant defense status prevents cytokine-induced nuclear factor-kappaB activation in insulin-producing cells.

Azevedo-Martins AK, Lortz S, Lenzen S, Curi R, Eizirik DL, Tiedge M.

Diabetes. 2003 Jan;52(1):93-101.

8.

NF-kappaB stimulates inducible nitric oxide synthase to protect mouse hepatocytes from TNF-alpha- and Fas-mediated apoptosis.

Hatano E, Bennett BL, Manning AM, Qian T, Lemasters JJ, Brenner DA.

Gastroenterology. 2001 Apr;120(5):1251-62.

PMID:
11266388
9.

Activation of retinoic X receptor and peroxisome proliferator-activated receptor-gamma inhibits nitric oxide and tumor necrosis factor-alpha production in rat Kupffer cells.

Uchimura K, Nakamuta M, Enjoji M, Irie T, Sugimoto R, Muta T, Iwamoto H, Nawata H.

Hepatology. 2001 Jan;33(1):91-9.

PMID:
11124825
10.
11.

Interaction of interferon regulatory factor-1 and nuclear factor kappaB during activation of inducible nitric oxide synthase transcription.

Saura M, Zaragoza C, Bao C, McMillan A, Lowenstein CJ.

J Mol Biol. 1999 Jun 11;289(3):459-71.

PMID:
10356322
12.

Effect of nitric oxide on the growth of Chlamydophila pneumoniae.

Carratelli CR, Rizzo A, Paolillo R, Catania MR, Catalanotti P, Rossano F.

Can J Microbiol. 2005 Nov;51(11):941-7.

PMID:
16333333
14.

Inhibition of Chlamydia pneumoniae replication in HEp-2 cells by interferon-gamma: role of tryptophan catabolism.

Mehta SJ, Miller RD, Ramirez JA, Summersgill JT.

J Infect Dis. 1998 May;177(5):1326-31.

PMID:
9593020
15.

Requirement of tumor necrosis factor alpha and nuclear factor-kappaB in the induction by IFN-gamma of inducible nitric oxide synthase in macrophages.

Vila-del Sol V, Díaz-Muñoz MD, Fresno M.

J Leukoc Biol. 2007 Jan;81(1):272-83. Epub 2006 Oct 11.

PMID:
17035338
16.

Casein kinase II-mediated phosphorylation of NF-kappaB p65 subunit enhances inducible nitric-oxide synthase gene transcription in vivo.

Chantôme A, Pance A, Gauthier N, Vandroux D, Chenu J, Solary E, Jeannin JF, Reveneau S.

J Biol Chem. 2004 Jun 4;279(23):23953-60. Epub 2004 Mar 19.

18.

Hypertonicity inhibits lipopolysaccharide-induced nitric oxide synthase expression in smooth muscle cells by inhibiting nuclear factor kappaB.

Pingle SC, Sanchez JF, Hallam DM, Williamson AL, Maggirwar SB, Ramkumar V.

Mol Pharmacol. 2003 Jun;63(6):1238-47.

19.

Fructus Xanthii extract protects against cytokine-induced damage in pancreatic beta-cells through suppression of NF-kappaB activation.

Song MY, Kim EK, Lee HJ, Park JW, Ryu DG, Kwon KB, Park BH.

Int J Mol Med. 2009 Apr;23(4):547-53.

PMID:
19288032
20.

Comparison of gamma interferon-mediated antichlamydial defense mechanisms in human and mouse cells.

Roshick C, Wood H, Caldwell HD, McClarty G.

Infect Immun. 2006 Jan;74(1):225-38.

Supplemental Content

Support Center